SCHEMBL5474472

SCHEMBL5474472

O=C(O)C(O)CCCS.[Fe]

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.52
FFAR1 O14842 1/20 0.52
FOLH1 Q04609 7/20 0.48
TET2 Q6N021 3/20 0.48
KDM4A O75164 2/20 0.48
KDM4C Q9H3R0 2/20 0.48
KDM2A Q9Y2K7 2/20 0.48
TET3 O43151 1/20 0.48
OR51E2 Q9H255 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
TBXAS1 P24557 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12838599 0.97
SCHEMBL6701489 0.97
SCHEMBL2844312 0.97
SCHEMBL5466268 0.95 GPR84 (0.52) GPR84FFAR1FOLH1TET2KDM4A
SCHEMBL5480495 0.95 GPR84 (0.52) GPR84FFAR1FOLH1TET2KDM4A
SCHEMBL5470511 0.95 GPR84 (0.52) GPR84FFAR1FOLH1TET2KDM4A
SCHEMBL5466935 0.95 GPR84 (0.52) GPR84FFAR1FOLH1TET2KDM4A
SCHEMBL5460635 0.95 GPR84 (0.52) GPR84FFAR1FOLH1TET2KDM4A
SCHEMBL902569 0.81
SCHEMBL3353937 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010583-A1 Methods and compositions for reducing blood homocysteine levels NOVUS INTERNATIONAL, INC. 2007-01-11 US claimed
WO-2006128048-A2 METHODS AND COMPOSITIONS FOR REDUCING BLOOD HOMOCYSTEINE LEVELS NOVUS INTERNATIONAL, INC. (US) 2006-11-30 WO claimed
US-20070010583-A1 Methods and compositions for reducing blood homocysteine levels NOVUS INTERNATIONAL, INC. 2007-01-11 US disclosed
WO-2006128048-A2 METHODS AND COMPOSITIONS FOR REDUCING BLOOD HOMOCYSTEINE LEVELS NOVUS INTERNATIONAL, INC. (US) 2006-11-30 WO disclosed